小单孢菌及其在海洋药物开发中的前景

小单孢菌是除链霉菌外,生产抗生素的另一大家族。从分类地位、生态分布、分离方法以及产生物活性物质的状况等方面,介绍了小单孢菌研究的历史和现状。展望了小单孢菌在海洋药物开发中的前景。     

小单孢菌叠加诱变与发酵过程的研究

采用庆大霉素产生菌—绛红小单孢菌 (M. purpurea) 在培养36h时添加15μg/ml的青霉素,对培养至48h对数生长期的菌体进行紫外线照射+亚硝基胍复合处理,置培养箱中37℃培养5~8d待长出菌落后再用紫外线照射叠加处理,获得一高产菌株N-14。试管发酵生测效价1913u/ml(对照625u/ml);摇瓶发酵培养120h达2178(u/ml),比对照(1243u/ml)提高75.2%;并进行了5L发酵罐发酵培养,发酵过程中测定了发酵液还原糖、总糖、氨基氮、pH、菌体浓度等代谢参数,探索了适合N-14的培养条件,连续5批次生测效价平均1967u/ml,较对照1171u/ml提高了68%, 效果明显。     

庆大霉素生物合成基因genA的功能

【目的】在绛红色小单孢菌G1008(Micromonospora purpurea G1008)上构建genA基因缺失工程菌,通过分析其次级代谢产物的变化,推测genA基因功能。【方法】构建用于gen A基因框内敲除的质粒pAB103,经接合转移导入绛红色小单孢菌G1008,安普抗性及PCR扩增筛选获得genA缺失工程菌GA1048。【结果】与出发菌G1008相比,工程菌GA1048不再合成庆大霉素C族组分,主要积累中间代谢产物庆大霉素A2。【结论】genA基因失活导致庆大霉素生物合成代谢流中断,暗示gen A基因参与加洛糖胺C-3″位的氨甲基化。     

不同生境放线菌的卤化酶基因分析及其对卤代产物筛选的意义

摘要：【目的】在基因水平上分析并比较陆地来源与海洋来源的放线菌产生卤化代谢产物的潜力。【方法】基于依赖黄素腺嘌呤二核苷酸的卤化酶基因筛选,从经过表型去重复的70株陆地来源和71株海洋来源的放线菌中,通过PCR筛选获得卤化酶基因片段,并进行测序鉴定;通过卤化酶氨基酸序列的系统发育分析,比较不同来源放线菌的卤化酶序列,以及海洋链霉菌和小单孢菌的卤化酶序列。另外,对卤化酶阳性菌株进行了聚酮合酶和非核糖体多肽合成酶基因的检测。【结果】本研究中36.6%的海洋放线菌具有卤化酶基因,其阳性率远高于本研究所涉及的陆地放     

小单孢菌40027菌株噬菌体的分离及其生物学特性的研究

以福堤霉素A产生菌──小单孢菌40027菌株为指示菌,从土壤中分离得到三株噬菌体:ΦHAU7、ΦHAU9和ΦHAU11。三株噬菌体的寄主专一性较强,在测试的15株放线菌菌株中,三株噬菌体能感染小单孢菌40027菌株和A-M-01菌株,ΦHAU9和ΦHAU11还能感染蔷薇小单孢菌(Micromonospora purprea)。三株噬菌体都是由多面体的头部和尾部组成;形成噬菌斑时培养基中适宜的Ca2 、Mg2 浓度分别为32mM和30mM;ΦHAU7在储存液中适宜的pH范围为6~12,而其它两株噬菌体的适宜的pH范围为6~10;在储存过程中三株噬菌体适宜的温度范围为28~37℃,经60℃保温30min后,除ΦHAU7仍有53%活力之外,其它两株噬菌体全部失活。限制性内切酶酶切结果表明:三株噬菌体基因组DNA均为双链DNA;基因组大小分别约为60kb、58kb和55kb。高压脉冲电泳结果揭示:三株噬菌体基因组DNA均具有粘性末端。     

链霉菌质粒pSET152电转化稀有放线菌小单孢菌的研究

利用链霉菌(Streptomyces)噬菌体ΦC31所构建的整合型载体pSET152作为供体质粒,分别以小单孢菌(Micromonospora)40027菌株的萌发孢子和新鲜菌丝体作为受体菌,在不同的电场强度下进行电转化实验,结果表明:以小单孢菌40027菌株萌发孢子为受体菌,未获得电转化子;以小单孢菌40027菌株新鲜菌丝体为受体菌,获得了电转化子。电场强度为13kV/cm时可获得最高转化效率。Southern杂交结果表明:质粒pSET152可通过菌丝体电转化法导入小单孢菌40027菌株,并整合到小单孢菌40027菌株的染色体上,暗示链霉菌噬菌体ΦC31的整合酶基因和整合位点在异源宿主小单孢菌40027菌株中仍具有相同的功能。质粒稳定性检测实验表明:质粒pSET152可稳定地存在于小单孢菌40027菌株中。     

Engineering sequence and selectivity of late-stage C-H oxidation in the MycG iterative cytochrome P450

MycG is a multifunctional P450 monooxygenase that catalyzes sequential hydroxylation and epoxidation or a single epoxidation in mycinamicin biosynthesis. In the mycinamicin-producing strain Micromonospora griseorubida A11725, very low-level accumulation of mycinamicin V generated by the initial C-14 allylic hydroxylation of MycG is observed due to its subsequent epoxidation to generate mycinamicin II, the terminal metabolite in this pathway. Herein, we investigated whether MycG can be engineered for production of the mycinamicin II intermediate as the predominant metabolite. Thus, mycG was subject to random mutagenesis and screening was conducted in Escherichia coli whole-cell assays. This enabled efficient identification of amino acid residues involved in reaction profile alterations, which included MycG R111Q/V358L, W44R, and V135G/E355K with enhanced monohydroxylation to accumulate mycinamicin V. The MycG V135G/E355K mutant generated 40-fold higher levels of mycinamicin V compared to wild-type M. griseorubida A11725. In addition, the E355K mutation showed improved ability to catalyze sequential hydroxylation and epoxidation with minimal mono-epoxidation product mycinamicin I compared to the wild-type enzyme. These approaches demonstrate the ability to selectively coordinate the catalytic activity of multifunctional P450s and efficiently produce the desired compounds.     

小单孢菌细胞壁中3－OHDAP的快速分析

本文介绍了用微结晶纤维素簿板层析对小单孢菌（Ｍｉｃｒｏｍｏｎｏｓｐｏｒａ）细胞壁中二氨基庚二酸（ＤＡＰ）异构体及其３－羟基衍生物（３－ＯＨＤＡＰ）进行快速分析的方法。在甲醇：水：冰乙酸：吡啶（１０：５：０．２５：１）的溶剂系统中测得Ｒ_{ＬＬ－ＤＡＰ}：ｍｅｓｏ－ＤＡＰ为０．８８,ＤＤ－ＤＡＰ为０．７８,３－ＯＨＤＡＰ为０．７２。     

Characterization of the biosynthetic gene cluster for the oligosaccharide antibiotic, Evernimicin, in Micromonospora carbonacea var. africana ATCC39149

Evernimicin (EV) belongs to the orthosomycin class of antibiotics and consists of several modified L- and D-deoxysugars containing unusual orthoester and glycosyl linkages and two orsellinic acid groups, one that is halogenated. The EV biosynthetic gene cluster from Micromonospora carbonacea var. africana ATCC39149 was localized by hybridization to a dTDP-D-glucose 4,6-dehydratase probe and a 120-kb region containing the EV biosynthetic cluster and surrounding regions has been sequenced. BLAST analysis has identified a type I polyketide synthase for orsellinic acid biosynthesis as well as enzymes required for L- and D-deoxyglucose and D-deoxymannose synthesis. In addition, genes involved in glycosyltransfer and resistance were identified. Insertional mutations in several biosynthetic genes blocked EV production, indicating a role for these genes in EV biosynthesis.